The <ENAMEX TYPE="ORGANIZATION">University</ENAMEX> of <ENAMEX TYPE="LOCATION">Toronto</ENAMEX> said it will drop its objections to the offer by Institut Merieux S A to acquire Connaught Biosciences <ENAMEX TYPE="ORGANIZATION">Inc</ENAMEX> for 942 million Canadian dollars US 803 7 million after reaching a research agreement with the French vaccine manufacturer Under the terms of the accord similar to an agreement reached last week between the university and Merieux s rival bidders for <ENAMEX TYPE="ORGANIZATION">Connaught Ciba Geigy Ltd</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">Chiron Corp Merieux</ENAMEX> agreed to spend 15 million Canadian dollars US 12 8 million to fund vaccine related research in <ENAMEX TYPE="LOCATION">Canada C</ENAMEX> 9 NNP million of which would go to the university s research programs The university had sued Connaught arguing its directors had broken a 1972 agreement not to sell the company to a foreign concern by recommending Merieux s offer to shareholders A decision in the case heard last week by the <ENAMEX TYPE="ORGANIZATION">Ontario Supreme Court</ENAMEX> is expected this week A decision in the university s favor could block Connaught s directors from recommending Merieux s offer to shareholders but couldn t block the company s sale <ENAMEX TYPE="PERSON">James Keffer</ENAMEX> vice president research at the university said the university isn t favoring one bid over another Both of these agreements are good both add substantial benefits to <ENAMEX TYPE="LOCATION">Canada</ENAMEX> he said Ciba Geigy and <ENAMEX TYPE="ORGANIZATION">Chiron</ENAMEX> are offering slightly more investment dollars to Canadian universities and some new products but Merieux is proposing to build a new biotechnology center Ciba Geigy a Swiss pharmaceutical company and <ENAMEX TYPE="LOCATION">California</ENAMEX> based <ENAMEX TYPE="ORGANIZATION">Chiron</ENAMEX> a pharmaceutical research concern are offering C 866 million or C 30 a share for Connaught The Canadian government said earlier this month that the proposed Merieux acquisition didn t appear to offer enough net benefit to <ENAMEX TYPE="LOCATION">Canada</ENAMEX> to approve Reaching an agreement is an advantage to both the university and Merieux both in terms of business and politically since the university has been quite vocal about the issue of foreign ownership said Philippe Stoeckel president of <ENAMEX TYPE="ORGANIZATION">Merieux Institute Inc Merieux</ENAMEX> s U S subsidiary